πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10208059

Heterocyclic modulators of HIF activity for treatment of disease

The Board of Regents of the University of Texas System Β· Granted Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10207013

Gadolinium-based contrast agents for sensitive detection of Zn2+ with MRI

The Board of Regents of the University of Texas System Β· Granted Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10201554

Esters of 2-deoxy-monosacharides with anti proliferative activity

The Board of Regents of the University of Texas System Β· Granted Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10195297

Iron garnet nanoparticles for cancer radiotherapy and chemotherapy

The Board of Regents of the University of Texas System Β· Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10196450

Anti-OX40 antibodies and methods of using the same

The Board of Regents of the University of Texas System Β· Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10183972

BK channel-modulating peptides and their use

The Board of Regents of the University of Texas System Β· Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10182997

Liposomal curcumin for treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10183011

Anti-depression compounds

The Board of Regents of the University of Texas System Β· Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10172827

Pro-neurogenic compounds

The Board of Regents of the University of Texas System Β· Granted Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10167259

Allosteric inhibitors of proteasome and methods of use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10167337

Combination immunotherapy for the treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10168337

Method and biomarkers for the detection of dengue hemorrhagic fever

The Board of Regents of the University of Texas System Β· Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10159765

Tissue engineered devices and methods for making same

The Board of Regents of the University of Texas System Β· Granted Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10155003

Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes,

The Board of Regents of the University of Texas System Β· Granted Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10154669

Improving color and release profile of resin compositions comprising silver nanoparticles

The Board of Regents of the University of Texas System Β· Granted Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10149836

Isoxazole treatments for frontotemporal dementia

The Board of Regents of the University of Texas System Β· Granted Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10150753

Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-

The Board of Regents of the University of Texas System Β· Granted Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10143658

Multistage delivery of active agents

The Board of Regents of the University of Texas System Β· Granted Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10125128

GLS1 inhibitors for treating disease

The Board of Regents of the University of Texas System Β· Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10125193

Chimeric antigen receptors and methods of making

The Board of Regents of the University of Texas System Β· Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10126309

Method for the detection of an albumin isoform

The Board of Regents of the University of Texas System Β· Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10117878

Ligands for nematode nuclear receptors and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10098878

HIF-2Ξ± inhibitors for treating iron overload disorders

The Board of Regents of the University of Texas System Β· Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10098971

Library of pH responsive polymers and nanoprobes thereof

The Board of Regents of the University of Texas System Β· Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted